AZN - AstraZeneca Imfinzi improves survival in late-stage lung cancer trial
2024-04-05 07:43:40 ET
More on AstraZeneca
- What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals
- 5 Reasons AstraZeneca Stock Can Rise In 2024
- AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript
- FDA accepts Daiichi Sankyo-AstraZeneca's breast cancer therapy for review
- AstraZeneca gets FDA approval for PNH drug Voydeya